FindTrial
Sign In

Pathogenesis and treatment of Coats disease

The treatment combination of anti-VEGF injections, laser coagulation and cryotheraphy on patients with Coat`s disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17011161
Enrollment
Unknown
Registered
2017-04-16
Start date
2013-04-01
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coats disease

Interventions

Cohort 1:intravitreal ranibizumab
Cohort 2:laser photocoagulation
Cohort 3:cryocoagulation

Sponsors

Beijing Tongren Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: initial treatment, previous history of no treatment; fundus and FFA examinations consistent with the diagnosis of Coats disease.

Exclusion criteria

Exclusion criteria: Excluding retinoblastoma, familial exudative retinopathy, ROP, PHPV and other eye diseases.

Design outcomes

Primary

MeasureTime frame
The retinal reattachment;intraocular pressure;BCVA;abnormal retinal blood vessels subside;—

Countries

China

Contacts

Public ContactHai Lu

Beijing Tongren Hospital Eye Centre

trdr_luhai@163.com+86 13701287425

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026